385 related articles for article (PubMed ID: 2217209)
61. The prevention of cancer.
Ames BN; Gold LS
Drug Metab Rev; 1998 May; 30(2):201-23. PubMed ID: 9606601
[TBL] [Abstract][Full Text] [Related]
62. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
63. Comparison between rodent carcinogenicity test results of 44 chemicals and a number of predictive systems.
Lewis DF
Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):215-22. PubMed ID: 7724831
[TBL] [Abstract][Full Text] [Related]
64. Rodent carcinogenicity bioassay: past, present, and future.
Boorman GA; Maronpot RR; Eustis SL
Toxicol Pathol; 1994; 22(2):105-11. PubMed ID: 7973358
[TBL] [Abstract][Full Text] [Related]
65. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
Shirai T; Hirose M; Ito N
IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
[No Abstract] [Full Text] [Related]
66. Cancer risk assessment: historical perspectives, current issues, and future directions.
Velazquez SF; Schoeny R; Rice GE; Cogliano VJ
Drug Chem Toxicol; 1996 Aug; 19(3):161-85. PubMed ID: 8933022
[No Abstract] [Full Text] [Related]
67. [Modification of the processes of chemical mutagenesis and carcinogenesis by synthetic phenol antioxidants such as butylated hydroxyanisole].
Demkowicz-Dobrzański K; Hennig EE
Postepy Biochem; 1992; 38(1):37-42. PubMed ID: 1508778
[No Abstract] [Full Text] [Related]
68. Multiple steps in carcinogenesis, multiple carcinogenic factors, and multiple primary tumors: can we develop an appropriate response for cancer prevention?
Nagao M; Sugimura T
Drug Metab Rev; 1998 May; 30(2):405-19. PubMed ID: 9606610
[No Abstract] [Full Text] [Related]
69. Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations.
Gollapudi BB; Stott WT; Yano BL; Bus JS
Toxicol Lett; 1998 Dec; 102-103():479-84. PubMed ID: 10022299
[TBL] [Abstract][Full Text] [Related]
70. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
Slamenová D
Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
[TBL] [Abstract][Full Text] [Related]
71. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
Johnson FM
Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
[TBL] [Abstract][Full Text] [Related]
72. Beware of a new carcinogenic risk: promotion of promoters.
Bounias M; Bonaly A
Toxicol Lett; 1995 Oct; 80(1-3):19-24. PubMed ID: 7482586
[TBL] [Abstract][Full Text] [Related]
73. The carcinogenesis bioassay in perspective: application in identifying human cancer hazards.
Fung VA; Barrett JC; Huff J
Environ Health Perspect; 1995; 103(7-8):680-3. PubMed ID: 7588478
[TBL] [Abstract][Full Text] [Related]
74. An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.
Cohen SM
Exp Toxicol Pathol; 2010 Sep; 62(5):497-502. PubMed ID: 19616417
[TBL] [Abstract][Full Text] [Related]
75. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
76. Preliminary estimates of the virtually safe dose for tumors obtained from the maximum tolerated dose.
Gaylor DW
Regul Toxicol Pharmacol; 1989 Apr; 9(2):101-8. PubMed ID: 2717786
[TBL] [Abstract][Full Text] [Related]
77. Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies.
Melnick RL; Thayer KA; Bucher JR
Environ Health Perspect; 2008 Jan; 116(1):130-5. PubMed ID: 18197312
[TBL] [Abstract][Full Text] [Related]
78. Risk from low-dose exposures.
Monro AM
Science; 1994 Nov; 266(5188):1141. PubMed ID: 7973684
[No Abstract] [Full Text] [Related]
79. Long-term assays for carcinogenicity.
Della Porta G; Dragani TA
Teratog Carcinog Mutagen; 1990; 10(2):137-45. PubMed ID: 1973852
[TBL] [Abstract][Full Text] [Related]
80. Rodent carcinogens: setting priorities.
Gold LS; Slone TH; Stern BR; Manley NB; Ames BN
Science; 1992 Oct; 258(5080):261-5. PubMed ID: 1411524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
